Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Skin Solution Co. Ltd. currently maintains 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is located within 1 distinct art unit, reflecting a very specific and narrow focus for the company's current patent prosecution. The absence of additional pending actions or art units suggests a highly targeted approach to its intellectual property in this field.
The portfolio is being examined by 1 distinct examiner, which simplifies the communication and negotiation process. WERTZ, ASHLEE ELIZABETH is the busiest examiner for the company, managing 1 busiest examiner pending action. This single action represents the total current workload for the portfolio, placing all active prosecution under this 1 individual's review.
For practitioners, the concentration of 1 pending office action under 1 distinct examiner in 1 distinct art unit allows for a dedicated strategy. There are no competing priorities or differing examiner styles to manage within the Biotechnology & Pharmaceuticals sector for this company. The prosecution environment is currently entirely centralized, with WERTZ, ASHLEE ELIZABETH serving as the sole point of contact for active matters.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WERTZ, ASHLEE ELIZABETH | 1 | 52.9% | +42.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18756063 | HYDROCOLLOID SHEET WITH EXFOLIATION PERFORMANCE | WERTZ, ASHLEE ELIZABETH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18756063 | HYDROCOLLOID SHEET WITH EXFOLIATION PERFORMANCE | WERTZ, ASHLEE ELIZABETH | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18756063 | HYDROCOLLOID SHEET WITH EXFOLIATION PERFORMANCE | WERTZ, ASHLEE ELIZABETH | 1612 | §102§103 | Non-Final OA | — | Pending | Jun 27, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial